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The neurotransmitter serotonin [5-hydroxytryptamine (5-HT)] modulates many key brain
functions including those subserving sensation, emotion, reward, and cognition. Efficient
clearance of 5-HT after release is achieved by the antidepressant-sensitive 5-HT
transporter (SERT, SLC6A4). To identify novel SERT regulators, we pursued a proteomic
analysis of mouse midbrain SERT complexes, evaluating findings in the context of
prior studies that established a SERT-linked transcriptome. Remarkably, both efforts
converged on a relationship of SERT with the synaptic adhesion protein neuroligin
2 (NLGN2), a post-synaptic partner for presynaptic neurexins, and a protein well-
known to organize inhibitory GABAergic synapses. Western blots of midbrain reciprocal
immunoprecipitations confirmed SERT/NLGN2 associations, and also extended to other
NLGN2 associated proteins [e.g., α-neurexin (NRXN), gephyrin]. Midbrain SERT/NLGN2
interactions were found to be Ca2+-independent, supporting cis vs. trans-synaptic
interactions, and were absent in hippocampal preparations, consistent with interactions
arising in somatodendritic compartments. Dual color in situ hybridization confirmed co-
expression of Tph2 and Nlgn2 mRNA in the dorsal raphe, with immunocytochemical
studies confirming SERT:NLGN2 co-localization in raphe cell bodies but not axons.
Consistent with correlative mRNA expression studies, loss of NLGN2 expression in
Nlgn2 null mice produced significant reductions in midbrain and hippocampal SERT
expression and function. Additionally, dorsal raphe 5-HT neurons from Nlgn2 null mice
exhibit reduced excitability, a loss of GABAA receptor-mediated IPSCs, and increased
5-HT1A autoreceptor sensitivity. Finally, Nlgn2 null mice display significant changes in
behaviors known to be responsive to SERT and/or 5-HT receptor manipulations. We
discuss our findings in relation to the possible coordination of intrinsic and extrinsic
regulation afforded by somatodendritic SERT:NLGN2 complexes.
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INTRODUCTION
In the mammalian central nervous system (CNS), serotonin
[5-hydroxytryptophan (5-HT)] acts as an essential modulatory
neurotransmitter, regulating a wide variety of brain functions
that range from sensory perception and pain responses to
emotion and cognition, among many others (Azmitia, 2007).
CNS serotonergic innervation originates from small clusters
of mesencephalic and brainstem dorsal raphe neurons, with
forebrain projections derived largely from dorsal and median
raphe nuclei (Abrams et al., 2004; Gaspar and Lillesaar,
2012). In both somatodendritic and synaptic compartments, the
availability of 5-HT is actively constrained by the high-aﬃnity,
antidepressant-sensitive 5-HT transporter (SERT, SLC6A4; Bunin
and Wightman, 1998; Montanez et al., 2003; Mathews et al.,
2004; Jennings et al., 2006). Alterations in SERT expression and
function have been implicated in a range of neurobehavioral
disorders including anxiety, depression, obsessive-compulsive
disorder and autism (Lesch et al., 1996; Ozaki et al., 2003; Sutcliﬀe
et al., 2005; Homberg and Lesch, 2011; Voyiaziakis et al., 2011).
Although SERT proteins have been the target of therapeutic
medications for decades, the endogenous mechanisms by which
SERT levels and activity are adjusted to meet the ongoing
demand for serotonergic neuromodulation remain to be fully
elucidated (Steiner et al., 2008), with evidence that perturbed
SERT regulation can contribute to disease risk (Ozaki et al., 2003;
Sutcliﬀe et al., 2005; Baudry et al., 2010; Veenstra-VanderWeele
et al., 2012).
SERT, like other neurotransmitter transporters (Sager and
Torres, 2011), appears to be dynamically regulated by protein–
protein interactions, though speciﬁc compartments and signals
regulating the abundance and localization of these complexes are
ill-deﬁned, particularly in vivo. Recent studies from our group
and others have revealed that SERT traﬃcking, activity and
sensitivity to signaling pathways are inﬂuenced by an array of
interacting proteins that include signaling enzymes (e.g., NOS1,
PKG, PP2A; Bauman et al., 2000; Chanrion et al., 2007; Steiner
et al., 2009), cell-surface receptors (e.g., A3AR and IL-1R; Zhu
et al., 2010, 2011), and scaﬀolding and cell adhesion proteins
(e.g., Hic-5, ITGB3; Carneiro and Blakely, 2006; Carneiro et al.,
2008). Recently, in order to nominate novel regulators of SERT
expression and 5-HT homeostasis, we implemented a gene-
driven, bioinformatics approach based on mRNA correlations
captured from midbrain transcriptomes of recombinant-inbred
mice (BXD; Ye et al., 2014a,b). Attesting to the potential utility
of this approach, we identiﬁed multiple genes whose expression
is well-known to inﬂuence 5-HT neuron identity, synthesis and
release, including the transcription factor gene Fev (also known
as Pet1), the 5-HT biosynthetic enzyme tryptophan hydroxylase
type 2 gene (Tph2), and the vesicular monoamine transporter
type 2 (VMAT2) gene (Slc18a2). Additionally, we identiﬁed a
number of geneswhose relationships to SERT and 5-HT signaling
have yet to be deﬁned. One such gene (Nlgn2) encodes the
trans-synaptic cell adhesion protein neuroligin 2 (NLGN2). We
found that strain variation in Nlgn2 mRNA levels exhibited a
signiﬁcant, positive correlation with strain variation of SERT
(Slc6a4) andTph2mRNA levels, suggesting thatNlgn2 expression
may be tightly coordinated with multiple dimensions of 5-HT
homeostasis.
In an eﬀort to obtainmore direct insights into SERT regulatory
machinery, we pursued a proteomic analysis of SERT-interacting
proteins, deﬁning speciﬁcity via parallel assessments of extracts
from Slc6a4 knockout mice. Remarkably, this eﬀort yielded
evidence of SERT:NLGN2 associations, as well as several other
proteins known to associate with NLGN2 at inhibitory synapses.
The convergence on NLGN2 of our prior SERT transcriptomic
with this proteomic eﬀort compelled a further evaluation of
the relationship between transporter and synaptic adhesion
protein. Our ﬁndings conﬁrm speciﬁc SERT:NLGN2 protein
associations. NLGN2 belongs to the neuroligin family, a family
of integral membrane, synaptic adhesion proteins that possess
an intracellular PDZ domain and an extracellular cholinesterase
domain (Arac et al., 2007; Koehnke et al., 2008). NLGN2 proteins
are expressed post-synaptically and form Ca2+-dependent, trans-
synaptic complexes with presynaptic neurexins (Nguyen and
Sudhof, 1997; Scheiﬀele et al., 2000). NLGN2/NRXN interactions
are believed to be important for the recruitment and assembly
of post-synaptic complexes that support inhibitory signaling
through GABAA receptors (Graf et al., 2004; Poulopoulos et al.,
2009), though other types of synapses also appear to demonstrate
these complexes (Chen et al., 2012; Takacs et al., 2013).
Importantly, in addition to NLGN2, we also identiﬁed in our
SERT proteomic eﬀort several other inhibitory synaptic proteins
including GABAA receptor subunits and the GABAA scaﬀolding
protein collybistin. The convergence on NLGN2 of our prior
SERT transcriptomic with proteomic eﬀort compelled a further
evaluation of the unexpected relationship between transporter
andNLGN2. Our ﬁndings conﬁrm speciﬁc SERT:NLGN2 protein
associations that are localized to cell body but not axonal
projections of 5-HT neurons. Moreover, molecular, physiological,
and behavioral changes evident in Nlgn2 null mice reveal a
reliance on multiple dimensions of 5-HT neuron homeostasis on
NLGN2 expression, leading to considerations of altered synaptic
adhesion complexes as potentially contributory to disorders
linked to perturbed 5-HT signaling.
MATERIALS AND METHODS
Animals and Genotyping
All studies with mice were performed under approved protocols
of the Institutional Animal Care and Use Committees of the
Vanderbilt University School of Medicine or of the Children’s
Hospital of Los Angeles, University of Southern California.
Animals were housed on a 12:12 light:dark cycle with lights
on at 6:00 AM and food and water provided ad libitum. Nlgn2
null mice (on C57BL/6, 129 mixed background) were obtained
from Jackson Labs (stock number: 008139). Our colony was
derived from four heterozygous breeding pairs and maintained
via het × het breeding paradigm. All subject animals were
derived from this breeding scheme, except as noted below. Mouse
genotyping was performed on genomic DNA extracted from
tail clips using the Extract-N-AMP tissue PCR kit (Sigma, St.
Louis, MO, USA) according to the manufacturer’s instructions.
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Genotyping was performed by PCR with oligonucleotides 5′
GTC TCA GTA AGC TTA TTT GAG AAG CCA A 3′
(RB4485), 5′ CTC TGG GCC TTC TCA GGA CTG TAC 3′
(RB4486), and 5′ GAG CGC GCG CGG CGG AGT TGT TGA
C 3′ (RB4487), based on Jackson Labs protocol. Genotypes
were determined by the presence or absence of WT (582 bp)
and mutant (565 bp) bands, as determined by agarose gel
electrophoresis.
Antibodies
SERT: guinea pig anti-5-HTT (#HTT-GP-Af1400, Frontier
Institute, Japan; 1:2,000 for western blots); rabbit anti-SERT
(#Pc177L, CalBioChem, Billerica, MA, USA, 1:1,000 for
immunohistochemistry); SERT anti-serum #48 (see Qian
et al., 1995, for co-immunoprecipitation). NLGN2: mouse
anti-NLGN2 (#129211, Synaptic Systems, Germany, 1:1,000
for western blots); rabbit anti-NLGN2 (#129203, Synaptic
Systems, Germany, 1:5,000 for immunohistochemistry);
goat anti-NLGN2 (#sc-14089, Santa Cruz, Dallas, TX,
USA, for co-immunoprecipitation). Neurexin: anti-NRXN
(#175003, Synaptic Systems, Germany, 1:1,000 for western
blots). Collybistin: anti-CB (#261003, Synaptic Systems,
Germany, 1:1,000 for western blots). Dopamine transporter
(DAT): mouse anti-DAT (generously provided by Dr.
Roxanne Vaughan, University of North Dakota School of
Medicine, 1:2,000 for western blots, Vaughan et al., 1993).
Norepinephrine transporter (NET): mouse anti-NET (NET05,
Mab Technologies, Stone Mountain, GA, USA, 1:1,000 for
western blots). β-actin: mouse anti-actin (#A3854; Sigma-
Aldrich, St. Louis, MO, USA; 1:10,000 for western blots).
HRP or ﬂuorophore conjugated secondary antibodies were
purchased from Jackson ImmunoResearch (West Grove, PA,
USA).
Western Blotting and
Co-immunoprecipitation
For western blotting, freshly dissected brain tissues were
homogenized in RIPA buﬀer (50 mMTris, pH 7.4, 150 mMNaCl,
1 mMEDTA, 1% TRITONX-100, 1% sodium deoxycholate, 0.1%
SDS) containing protease inhibitors (P8340, 1:100; Sigma, St.
Louis, MO, USA). Protein concentrations were determined by
the BCA method (ThermoFisher, Waltham, MA, USA). Protein
lysates were centrifuged for 15 min at 16,060 × g and equal
amounts of supernatants were separated by 10% SDS-PAGE,
blotted to PVDF (Bio-Rad, Hercules, CA, USA) membrane
and then incubated with primary and secondary antibodies at
dilutions noted above. Immunoreactive bands were identiﬁed by
chemiluminescence (Western Lightning ECL Pro, Perkin Elmer)
and X-ray ﬁlm (Biomax MS, Kodak, 8294985) exposure. Multiple
exposures were obtained to ensure linearity of data capture.
For SERT co-immunoprecipitation assays, protein A Dynabeads
(Invitrogen) were ﬁrst cross-linked with an anti-SERT serum
#48 using dimethyl pimelimidate (DMP; Schneider et al., 1982).
Brieﬂy, beads were washed 3X in PBS at room temp followed by
incubation with #48 anti-SERT serum at 4◦C for 1 h. Antibody-
bound beads were then incubated with 6.5 mg/mL DMP in 0.2 M
Triethylamine (TEA) buﬀer for 30 min at room temperature.
The incubation step was repeated 3X with freshly made DMP
buﬀer each time. Cross-linked beads were then quenched in
50 mM ethanolamine (EA) buﬀer for 5 min at room temp,
washed 2X in 1 M glycine (pH = 3) buﬀer, and then 3X in
PBS (10 min, room temp). For NLGN2 co-immunoprecipitation,
protein G Dynabeads (Invitrogen) were washed 3X in PBS before
incubation with anti-NLGN2 polyclonal antibody (Santa Cruz)
for 1 h at room temperature. Beads were washed 3X in PBS
buﬀer before use. For all co-immunoprecipitation assays, brain
tissues were homogenized in homogenization buﬀer (50 mM
Tris, 150 mM KCl, 1 mM DTT, 1 mM EDTA, 0.5% N-dodecyl-
β-D-maltopyranoside, pH 7.4) with protease inhibitors (1:100,
Sigma) followed by 1 h incubation at 4◦C. Protein lysates were
collected by centrifugation at 16,060 × g for 10 min. Protein
lysates and beads were mixed and incubated at 4◦C for overnight,
and washed 4X in washing buﬀer (PBS, 0.1% Triton X-100).
Immunocomplexes were eluted by incubating beads with 2X
Laemmli sample buﬀer at 70◦C for 10 min. Eluted samples were
subjected for SDS-PAGE, electrotransferred to PVDFmembranes
andWestern blotting as noted above.
Proteomic Evaluation of SERT
Complexes
Proteomic analysis was performed in the Vanderbilt Proteomics
Core Facility of the Mass Spectromery Research Center.
SERT immunocomplexes eluted from the antibody-conjugated
dynabeads were ﬁrst resolved for 6 cm using a 10%Novex precast
gel, followed by in-gel tryptic digestion (55◦C, 1 h) to recover
peptides. Peptides were analyzed via MudPIT (Multidimensional
Protein Identiﬁcation Technology1 ,2). Brieﬂy, digested peptides
were loaded onto a biphasic pre-column consisting of 4 cm of
reversed phase (RP) material followed by 4 cm of strong cation
exchange (RP) material. Once loaded, this column was placed in
line with a 20 cm RP analytical column packed into a nanospray
emitter tip directly coupled to a linear ion trap mass spectrometer
(LTQ XL, ThermoScientiﬁc, Waltham, MA, USA). A subset
of peptides were eluted from the SCX material onto the RP
analytical column via a pulse of volatile salt, with eluted material
then separated by an RP gradient, and then ionized directly
into the mass spectrometer. Data derive from eight salt elution
steps over the course of approximately 16 h. Both the intact
masses (MS) and fragmentation patters (MS/MS) of the peptides
were collected and the peptide MS/MS spectral data searched
against the mouse protein database using Sequest3. Resulting
identiﬁcations were collated and ﬁltered using IDPicker4 and
Scaﬀold5.
In situ Hybridization
Adult mice were anesthetized with isoﬂuorane prior to
decapitation and brain removal. All brains were immediately
1http://www.pnas.org/content/99/12/7900.short
2http://www.jlr.org/content/53/3/379.short
3http://pubs.acs.org/doi/abs/10.1021/ac00104a020
4http://www.ncbi.nlm.nih.gov/pubmed/19522537
5http://www.proteomesoftware.com
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frozen in ice-cold isopentane and stored at −80◦C. Fresh-frozen
brains were cryosectioned in the coronal plane at 25 μm and
collected on Superfrost Plus glass slides (Fisher, Pittsburgh,
PA, USA). Slides were sored at −80◦C. Commercially available
RNAscope ISHMultiplex kits and probes were purchased directly
from Advanced Cell Diagnostics, Hayward, CA, USA. ISH probes
were: Mm-Nlgn2 (probe region: 3850–4910 bp of GenBank
NM_198862.2; C1), Mm-Tph2-C2 (probe region: 1640–2622 bp
of GenBank NM_173391.3; C2), and Mm-Slc6a4-C2 (probe
region: 452–1378 bp of GenBank NM_010481.2; C2). Each
set of target probes contains a tag that enables the target
to be visualized in a speciﬁc color channel: C1, excitation
495 nm/emission 520 nm and C2, excitation 555 nm/emission
575 nm. In situ hybridization was performed according to the
manufacturer’s recommendation. Brieﬂy, slides were ﬁrst post-
ﬁxed with pre-chilled freshly made 4% paraformaldehyde for
15 min at 4◦C followed by dehydration with 50% ethanol,
70% ethanol, and 100% ethanol at room temp for 5 min each.
Dehydrated slides were stored at −20◦C until the next day
for hybridization. Hybridization was performed at 40◦C for
2 h in a HybEZ oven (Advanced Cell Diagnostics, Hayward,
CA, USA) after pretreating slides with Protease Pretreat 4
(Advanced Cell Diagnostics, Hayward, CA, USA) at room temp
for 30 min. After wash and ampliﬁcation steps, Prolong Gold
with DAPI (Life Technology, Carlsbad, CA, USA) was used to
mount the coverslips. A multiplex positive control probe mix
consisting of probes against three diﬀerent house keeping genes,
Polr2a (C1), Ppib (C2), and Ubc (C3), and negative control
probes against a bacterial gene, dapB (all three channels), were
purchased from Advanced Cell Diagnostics and were used as
references for the signal intensity and background level in each
channel. Images were acquired using a Zeiss Axio Observer
inverted confocal microscope ﬁtted with an LSM700 confocal
scanner (Cellular Imaging Core at the Saban Research Institute at
Children’s Hospital Los Angeles). Figures were prepared digitally
in Adobe Photoshop CS5.1 (Adobe Systems, Inc., San Jose, CA,
USA).
Immunohistochemistry
Mice used for immunohistochemistry were anesthetized
by intraperitoneal pentobarbital injection (65 mg/kg), and
subjected to intracardiac perfusion with cold PBS (pH 7.4)
followed by 4% freshly prepared paraformaldehyde. Brains
were immediately removed, post-ﬁxed in the same ﬁxative
at 4◦C overnight and then cryoprotected in 30% sucrose.
Brains were then frozen and sectioned (40 μm) using a
sliding microtome (Leica SM-2000). Free-ﬂoating sections
were washed 3X in PBS buﬀer and blocked in PBS buﬀer
containing 0.2% Triton-X and 3% normal donkey serum for
1 h at room temperature. The sections were incubated with
primary antibodies overnight at 4◦C followed by ﬂuorophore-
conjugated secondary antibodies (2 h, room temperature).
Images were obtained in the Vanderbilt Cell Imaging Shared
Resource using a Zeiss Axio Imager M2 microscope equipped
with X-Cite 120 laser source (Lumen Dynamics). Confocal
images were obtained using a Zeiss LSM 510 Meta confocal
microscope.
Brain Tissue Neurochemical
Measurements
For assessment of 5-HT, 5-HIAA, glutamate, and GABA levels
in WT and Nlgn2 null mice, tissues were homogenized using
an Omni Tissue Homogenizer, in 100–750 μl of 0.1 M
trichloroacetic acid (TCA), 10 mM sodium acetate, 0.1 mM
EDTA, 5 ng/ml isoproterenol (as internal standard), and 10.5%
methanol (pH 3.8). 5-HT and 5-HIAA were determined by
HPLC through the Neurochemistry Core of the Vanderbilt
Brain Institute, utilizing an Antec Decade II (oxidation: 0.5)
electrochemical detector operated at 33◦C. Twenty μl samples of
the supernatant were injected using a Water 717+ autosampler
onto a Phenomenex Nucleosil (5 μm, 100A) C18 HPLC column
(150 mm × 4.60 mm). Samples were eluted with a mobile phase
consisting of 89.5% 0.1 M TCA, 10 mM sodium acetate, 0.1 mM
EDTA and 10.5% methanol (pH 3.8). Solvent was delivered at
0.6 ml/min using a Waters 515 HPLC pump. HPLC control
and data acquisition were managed by Millennium 32 software.
Amino acids were evaluated using the Waters AccQ-Tag system
and detected with a Waters 474 Scanning Fluorescence Detector.
Ten μl samples of the supernatant were diluted with 70 μL
of borate buﬀer to which 20 μL aliquots of 6-aminoquinol-N-
hydroxysuccinimidyl carbamate and 10 μL 250 pmol/μL alpha-
aminobutyric acid (as internal standard) were added to form
the ﬂuorescent derivatives. After heating the mixture for 10 min
at 37◦, 10 μL of derivatized samples were injected into the
HPLC system, consisting of a Waters 2707 Autosampler, two
510 HPLC pumps, column heater (37◦C) and the ﬂuorescence
detector. Separation of the amino acids was accomplished by
gradient elution over a Waters amino acid column and supplied
buﬀers (A – 19% sodium acetate, 7% phosphoric acid, 2%
triethylamine, 72% water; B – 60% acetonitrile). HPLC control
and data acquisition was managed by Empower 2 software.
Synaptosomal [3H]-5-HT Transport
Activity Measurements
Mouse brain synaptosomes were prepared as previously
described (Zhu et al., 2011). Brieﬂy, freshly dissected brain
tissues were homogenized in 0.32 M sucrose buﬀer with 10 mM
HEPES and 2 mM EDTA (pH = 7). P2 pellets were obtained
by centrifugation, resuspended in KRH assay buﬀer containing
130 mM NaCl, 1.3 mM KCl, 2.2 mM CaCl2, 1.2 mM MgSO4,
1.2 mM KH2PO4, 1.8 g/L D-glucose, 10 mM HEPES, pH 7.4,
100 μM pargyline, and 100 μM ascorbic acid, and protein
quantiﬁed by BCA method (Pierce). Radiolabeled [3H]-5-HT
uptake into synaptosomes (40 μg) was performed for 10 min at
37◦C and terminated using a Brandel Cell Harvester (Brandel),
as previously described. Non-speciﬁc uptake was determined
using parallel samples incubating with 10 μM paroxetine with
levels here subtracted from total accumulation to yield speciﬁc
uptake activity.
Electrophysiology
Whole Cell Recordings
For 5-HT whole cell recordings, Nlgn2−/− mice were ﬁrst
crossed to a Tph2::ChR2-EYFP line (Zhao et al., 2011). The
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oﬀspring of these breeding were then bred to Nlgn2+/− mice
to generate WT and Nlgn2−/− mice with YFP-labeled 5-HT
neurons. Acute brain slices (190 μm thickness) were prepared
in oxygenated ice-cold sucrose-substituted artiﬁcial cerebrospinal
ﬂuid (aCSF) or NMDG-aCSF6 using a vibratome (VT1000S,
Leica Biosystems, Nussloch, Germany). The slices were incubated
with oxygenated aCSF (124 mM NaCl, 2.8 mM KCl, 2 mM
CaCl2, 2 mM MgSO4, 1.25 mM NaH2PO4, 26 mM NaHCO3,
10 mM D-glucose, pH 7.4) at room temperature for 1 h
before using. YFP-expressing serotonergic neurons were chosen
under a ﬂuorescence microscope (Axioskope 2 FS, Carl Zeiss
MicroImaging, Thornwood, NY, USA). To measure spontaneous
inhibitory post-synaptic currents (sIPSCs) in DR neurons, whole-
cell voltage clamp (−70 mV) was performed in aCSF at a
perfusion rate of 0.5 mL/min at 32◦C. Pulled glass pipettes
(5 M) were ﬁlled with high chloride solution (150 mM KCl,
5 mM NaCl, 10 mM HEPES, 1 mM EGTA, 2 mM MgCl2,
2.5 mM Na2ATP, 0.2 mM Na2GTP, 10 mM D-glucose, pH
7.4). Series resistance was limited to less than 40 M and
compensated 90% with a 60 μs lag. Calculated liquid junction
potentials (3.6 mV) were not adjusted in our experiments. sIPSC
were recorded for 10 min at a 5 kHz sampling rate in the
presence of the AMPA receptor antagonist CNQX (10 μM).
GABAergic nature of sIPSC was validated using the GABAA
receptor antagonist gabazine (10 μM). After high-pass (1 Hz)
and low-pass (2 kHz) ﬁltering, sIPSC events were detected
by scaled template ﬁtting-method (Clements and Bekkers,
1997) in Clampﬁt software (Molecular Devices, Sunnyvale,
CA, USA). The template was created with accumulation of
clearly visible events (>50 events) and the template time course
parameters were ﬁtted to the data at template match threshold
4. A Kolmogorov–Smirnov test in Clampﬁt was performed to
compare cumulative distribution histograms. To quantitative
5-HT1A autoreceptor-mediated serotonergic inhibition, 5HT1A
agonist-induced hyperpolarization was measured (Beck et al.,
2004; Audero et al., 2013). The intracellular solution was
composed of 135 mM K-Gluconate, 10 mM KCl, 5 mM HEPES,
0.5 mM EGTANa4, 2 mM MgCl2, 2.5 mM Na2ATP, 0.2 mM
Na2GTP, pH 7.4). Under whole-cell current-clamp made with
+50 pA current injection, we perfused slices with the 5-HT1A
receptor agonist 8-OH-DPAT (1 μM) to inhibit serotonergic
ﬁring. For analysis, baselines were normalized to the threshold
for action potential ﬁring. Recordings were obtained with an
Axopatch 200B ampliﬁer (Molecular Devices) connected to a
Digidata 1322A Digitizer (Molecular Devices) under the control
of a Windows 7-based 32-bit computer equipped with Clampex
10.2 software (Molecular Devices).
Multi-neuron Recordings
Array-based, multi-neuron recordings were performed as
previously described (Green et al., 2015). Brieﬂy, mice were
euthanized by cervical dislocation, brains were extracted and
mounted in cold, oxygenated (95% O2–5% CO2) dissecting
media (114.5 mM NaCl, 3.5 mM KCL, 1 mM NaH2PO4, 1.3 mM
MgSO4, 2.5 mM CaCl2, 10 mM D-glucose, and 35.7 mM
6www.brainslicemethods.com
NaCHO3), and 280 μm thick coronal slices were taken using
a Vibroslicer (Campden Instruments). The dorsal raphe nuclei
were isolated by removing the extraneous cortical tissue and
placed sample in a slice chamber full of room temperature,
oxygenated, extracellular recording media (124 mM NaCl,
3.5 mM KCl, 1 mM NaH2PO4, 1.3 mM MgSO4, 2.5 mM CaCl2,
10 mM D-glucose, and 20 mM NaHCO3). Mid-DR slices of
280 μm thickness were taken between −4.5 and −4.75 mm
back from bregma. We used a 6X10 perforated array with
electrodes that have a diameter of 30 and 100μm spacing between
electrodes. Once mounted on the array the slice was allowed to
settle for at least 45 min. Oxygenated, extracellular recording
media (in mM: 124 NaCl, 3.5 KCl, 1 NaH2PO4, 1.3 MgSO4, 2.5
CaCl2, 10 D(+)-glucose, and 20 NaHCO3) containing 40 μM
tryptophan and 3μMphenylnephrine was perfused over the slice
at a rate of 1.3 ml/min during acclimation period as well as during
recording. Putative 5-HT neurons were identiﬁed by feedback
inhibition evoked by application of 8-OH-DPAT (1 μM) for
5 min, with those cells demonstrating a minimum of 50% spike
rate suppression being included in the analysis, as has been done
in previously published studies (Thompson et al., 2011; Veenstra-
VanderWeele et al., 2012). The threshold for detection was set
manually to a level that will include all legitimate spikes with the
least amount of unipolar noise spikes included (between 13 and
35 μV). Once the total number of spikes was determined for the
period of the recording before the application of 5-HT or 8-OH-
DPAT that number was divided by the total time in which those
spikes occurred to produce a measure of spikes per second.
Animal Behavior Testing
Tail Suspension Test (TST)
Mice were suspended from the edge of a shelf by their tails,
secured by an adhesive tape approximately 1 cm away from
the tip of the tail. Each trial was conducted for a period of
6 min. Total immobility time wasmeasured by using the program
iCheckClock (Sgmultimedia7). Mice were deemed immobile
when they hung passively and were completely motionless.
Forced Swim Test (FST)
Mice were gently lowered into a transparent Plexiglas cylinder
(20-cm diameter) ﬁlled halfwaywith water (25± 1◦C) for a 6-min
session. The water was changed after each mouse tested. Total
immobility time was measured as in the TST. Mice were deemed
immobile when ﬂoating motionless or making only necessary
movement to keep aﬂoat.
DOI-Induced Head Twitch
Mice were administered 1.0 mg/kg of 1-(2,5-dimethoxy-4-
idophenyl)-2-aminopropane (DOI; Sigma, St. Louis, MO, USA)
in PBS solution via injection (i.p.) in a volume of 10 mL/kg.
Thirty-four minutes post-injection, each mouse was placed in
a large glass beaker containing their home cage bedding. Two
researchers who were blind to genotype independently counted
the number of head twitches during a 15-min test period.
7https://software.com/mac/productivity/icheckclock/2.0.2
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Tube Test
Tube test assays for social dominance were performed as
previously described (Veenstra-VanderWeele et al., 2012).
Brieﬂy, a clear acrylic tube 30-cm-long, 3.5-cm-diameter with
small acrylic funnels added to each end to facilitate entry into the
tube was used. On two separate days before testing, each mouse
was exposed to the tube, with progress through the tube resulting
in the mouse being returned to the home cage. For the tube test
bouts, one Nlgn2 null and one WT mouse of the same sex and
age, but from diﬀerent home cages, were placed at opposite ends
of the tube and released. A subject was deemed a “winner” when
its opponent backed out of the tube.
Statistical and Graphical Analyses
Data from experiments was analyzed and graphed using Prism
5.0 (GraphPad Software, Inc., La Jolla, CA, USA). For all analyses,
a P < 0.05 was taken to infer statistical signiﬁcance. Speciﬁc
details of statistical tests are given in Figure Legends.
RESULTS
SERT and NLGN2 form Midbrain-Specific
Protein Complexes
To pursue an unbiased approach to identify novel SERT
interacting proteins, we immunoprecipitated SERT protein
complexes from midbrain lysates prepared from WT and SERT
null mice, using beads covalently coupled to SERT anti-serum
#48 (Qian et al., 1995). SERT-associated immunocomplexes were
eluted through competition binding of the C-terminal SERT
peptide #48 was raised against. MudPIT (Multi-dimensional
Protein Identiﬁcation Technology, Wolters et al., 2001) analysis
was used to isolate peptides and aﬀord SERT-associated protein
identiﬁcation. From the 853 proteins identiﬁed in MudPIT
analyses, 45 proteins were identiﬁed in WT but not SERT null
samples, with an additional 80 proteins showing higher than
two-fold enrichment in WT compare to SERT null samples
(Supplementary File 1). In the list of proteins, we identiﬁed
peptides derived from protein phosphatase 2A catalytic subunit,
a protein we previously identiﬁed as a SERT partner, supporting
the utility of our proteomic approach. Also within this group,
we identiﬁed NLGN2 based on two diﬀerent peptides (AA
41–50 and 231–243). This ﬁnding drew our attention as we
had previously identiﬁed Nlgn2 in our study of genes whose
expression signiﬁcantly correlated with midbrain SERT mRNA
levels across BXD recombinant inbred lines (Ye et al., 2014a,b).
Adding signiﬁcance to this ﬁnding was our recovery of GABAA
receptor α2 subunit (two peptides WT, one peptide null).
Additionally, several proteins known to be co-localized with
NLGN2 at inhibitory synapses (Poulopoulos et al., 2009; Gauthier
et al., 2011), including the presynaptic NLGN2 partner NRXN2
and the GDP/GTP exchange factor collybistin, were identiﬁed in
separate proteomic assays.
To validate our proteomic ﬁndings, we performed co-
immunoprecipitation assays using midbrain extracts from WT
and SERT null mice, capturing complexes with SERT or
NLGN2 antibodies and blotting for the other protein. As
predicted, we obtained clear evidence for the presence of
NLGN2 in midbrain SERT complexes using extracts from
WT animals, but not with extracts from SERT null mice
(Figure 1A). Similarly, co-immunoprecipitations of NLGN2
recovered SERT from NLGN2 from WT but not NLGN2 null
extracts (Figure 1B). We also detected several known NLGN2
interacting proteins in these samples, including α-NRXN and
collybistin. Blotting of NLGN2 null mice revealed detection
by NLGN2 antibody of proteins other than NLGN2, which
prior studies indicates is NLGN3, at a higher molecular
weight (Dr. Frédérique Varoqueaux, Max-Planck Institute for
Experimental Medicine). Importantly, the NLGN3 species was
absent from SERT immunocomplexes, adding further evidence of
the speciﬁcity of SERT/NLGN2 interactions and suggesting that
other NLGN-associated proteins in SERT immunoprecipitates
derive from NLGN2. Finally, we investigating the speciﬁcity
of NLGN2 interactions with respect to other neurotransmitter
transporters expressed in the midbrain. Although as expected,
DAT and NET proteins were well-represented in total extracts,
neither protein was detected in NLGN2 immunoprecipitates
(Figure 1C).
Although conspicuous due to our prior BXD transcriptome
studies, our identiﬁcation of a midbrain SERT:NLGN2 complex
was puzzling because NLGN2 has been well-documented to
be a post-synaptic component of inhibitory synapses typically
found on somatodendritic membranes (Poulopoulos et al., 2009;
Panzanelli et al., 2011), whereas SERT is traditionally considered a
marker for axonal membranes of raphe 5-HT neurons. However,
SERT is synthesized in midbrain raphe soma and expressed
somatodendritically (Hensler et al., 1994; Qian et al., 1995; Lau
et al., 2010; Colgan et al., 2012), and thus we reasoned that
SERT:NLGN2 associations might derive from an interaction in
these compartments. We thus sought to determine whether
NLGN2-SERT protein complexes are present in brain regions
where SERT is only present on axonal membranes, performing
co-immunoprecipitation studies from hippocampal extracts. As
shown in Figures 1A,B, although both SERT and NLGN2 are
readily detected in total hippocampal extracts, SERT:NLGN2
complex were not recovered in these samples, using either SERT
or NLGN2 co-immunoprecipitations.
The regional speciﬁcity of our ﬁndings suggested
that SERT:NLGN2 complexes might be a feature of the
somatodendritic membrane of raphe 5-HT neurons. However,
NLGN2 supports interactions between pre- and post-synaptic
membranes, and the SERT interactions could arise either in
cis, where SERT and NLGN2 exist in a complex in the same
membrane, or in trans, where presynaptic SERT might link
to post-synaptic NLGN2 via the transporter’s cis interactions
with presynaptic NRXN proteins. Indeed, in addition to our
identiﬁcation of NRXN-2 peptides in our proteomic studies,
we detected, using a pan-neurexin antibody, α-NRXN, the
long splicing isoform of NRXN (Treutlein et al., 2014), in
SERT immunoprecipitates (Figure 2). Because NLGN:NRXN
interactions are Ca2+-dependent (Ichtchenko et al., 1996), it
is possible to distinguish between cis and trans interactions
of SERT with NLGN2 via treatment of extracts with a Ca2+-
chelator prior to immunoprecipitation. We found that treatment
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FIGURE 1 | NLGN2 forms midbrain-specific protein complexes with SERT. (A) Co-immunoprecipitation assay with SERT antibody, using SERT null mice as
negative controls; (B) Co-immunoprecipitation assay with NLGN2 antibody, using NLGN2 null mice as negative controls, NRXN: neurexin, Cb: collybistin; (C) NLGN2
does not form protein complexes with dopamine transporter (DAT) or norepinephrine transporter (NET). Input lanes represent 1% of total protein lysates, co-IP lanes
represent 40% of total eluants. Each blot is a representative of three or more independent experiments.
of midbrain extracts with EGTA treatment prior to SERT
immunoprecipitation completely eliminated recovery of
α-NRXN without impacting the recovery of SERT or NLGN2.
These ﬁndings strongly argue for a cis model of NLGN2-
SERT interactions where NLGN2 and SERT are complexed on
somatodendritic membranes across from presynaptic terminals
that elaborate α-NRXN, leading to co-immunoprecipitation of
α-NRXN with SERT due to transporter:NLGN2 interactions.
NLGN2 is Expressed in Dorsal Raphe
5-HT Neurons and Co-localizes with
SERT on 5-HT Cell Bodies
Although our biochemical studies provide strong evidence for
expression of NLGN2 by dorsal raphe 5-HT neurons, no previous
studies have been published that deﬁne sites of expression of
NLGN2 in the midbrain. To visualize the expression of the Nlgn2
mRNA, we used a multicolor in situ hybridization approach
(RNAscope, ACD), determining the pattern of Nlgn2 mRNA
localization in parallel with that of Tph2 as a marker of 5-HT
neurons. Tph2 labeling displayed the well-known distribution of
5-HT neurons in the DRN (Figure 3A). We found Nlgn2mRNA
to be more broadly expressed, though not ubiquitously (see DAPI
probe, Figures 3B,C). Importantly, essentially all Tph2 positive
FIGURE 2 | Midbrain NLGN2:SERT interaction is Ca2+-independent.
Co-immunoprecipitation assays using SERT antibody were performed with
(EGTA lanes) or without (control lanes) the presence of Ca2+ chelator EGTA
(10 mM). SERT-bound neurexin was largely removed under Ca2+ free
conditions, whereas NLGN2 remained bound to SERT, suggesting neurexin is
associated with SERT through NLGN2. Input lanes represent 1% of total
protein lysates, co-IP lanes represent 40% of total eluents. Blot is a
representative of three independent experiments.
soma were double labeled with the Nlgn2 probe (Figure 3D). To
conﬁrm these ﬁndings at the protein level, we performed multi-
color immunoﬂuorescence labeling of DRN sections with SERT
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FIGURE 3 | NLGN2 mRNA and proteins are expressed in the dorsal raphe nucleus (DRN) and co-localize with SERT in 5-HT cell bodies. (A–D) Nlgn2
mRNA co-localizes with Tph2 gene expression in DRN 5-HT neurons (scale bar: 100 μm); (E–G) NLGN2 proteins co-localize with SERT on 5-HT cell bodies in DRN
(arrowheads, scale bar: 100 μm). Insets: confocal image of NLGN2:SERT co-localization on the cell body a single 5-HT neuron (scale bar: 5 μm); (H–J) SERT
expressed on midbrain axonal fibers of 5-HT neurons but does not co-localize with NLGN2 (scale bar: 5 μm).
and NLGN2 antibodies. Consistent with our mRNA studies, we
readily detected double labeling of cells with SERT and NLGN2
in DRN cell bodies (Figures 3E–G) whereas little or no co-
localization was evident in axon proﬁles coursing through the
surrounding neuropil (Figures 3H–J). Staining of raphe cells
was dramatically diminished in sections from NLGN2 KO mice
(data not shown). At higher resolution, somatodendritic co-
labeling appeared punctate, either representing sites of surface
expression or submembraneous biosynthetic compartments.
Although additional studies are needed to explore potential
subsets of serotonergic neurons supporting NLGN2 expression,
these observations are consistent with themodel that dorsal raphe
SERT:NLGN2 interactions occur in cis on the somatodendritic
membrane and not in axonal compartments, either in the
midbrain or forebrain projection areas.
SERT Expression is Reduced in
Constitutive NLGN2 Null Mice
Our previous BXD studies revealed a strong positive correlation
between Slc6a4 and Nlgn2 mRNA variation. To test whether this
relationship holds at the protein level, we evaluated SERT protein
expression in Nlgn2 null mice. In western blots, we observed
a signiﬁcant Nlgn2 gene-dosage dependent decrease of SERT
protein levels in midbrain extracts (Figures 4A,B), with Nlgn2
null mice displaying a more than 50% of reduction in transporter
protein compared to their WT littermates (see also Figure 1B),
and Nlgn2+/− extracts demonstrating intermediate SERT levels.
Interestingly, we also found equivalent SERT protein reductions
in hippocampal extracts, where we do not recover SERT:NLGN2
complexes. These observations suggest that loss of SERT protein
expression arises from an indirect impact of loss of NLGN2
that ultimately inﬂuences raphe neuron biosynthetic capacity
for SERT and possibly other molecules. To determine whether
the protein downregulation is reciprocal between NLGN2 and
SERT, we also quantiﬁed NLGN2 expression in SERT null
mice and their WT littermate controls and found that NLGN2
expression levels did not diﬀer between WT and SERT null mice
(Figures 4C,D). We could not detect any gross diﬀerences in
dorsal raphe 5-HT neuron numbers or morphology, as visualized
by 5-HT staining (data not shown) and midbrain levels of 5-
HT and 5-HT turnover (5-HIAA/5-HT), as assessed by HPLC
analysis of tissue extracts, were normal (Figure 5). To determine
whether loss of SERT protein in Nlgn2 null mice impacts
nerve terminal 5-HT uptake capacity, we measured uptake
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of radiolabeled 5-HT uptake in midbrain and hippocampal
synaptosomes, detecting signiﬁcant reductions at a saturating
substrate concentration (1 μM, Figure 6). Altogether, these
ﬁndings reveal a dependence of SERT expression and activity
on NLGN2 levels, likely arising from the changes in SERT
mRNA expression predicted by our BXD studies (Ye et al.,
2014a,b).
NLGN2 Null Mice Display Altered 5-HT
Neuron Physiology
A loss in SERT levels in the Nlgn2 null in both the midbrain
and hippocampus suggests that NLGN2 is required for 5-
HT neurons to maintain speciﬁc aspects of their functional
identity. To gain an initial evaluation of how loss of NLGN2
could impact 5-HT neuron excitability, we utilized a multi-
electrode recording array system (Green et al., 2015) to
monitor basal 5-HT neuron activation in acute midbrain
slices. In this approach, the array detects the ﬁring of
neurons in the slice overlying the dorsal raphe nucleus in
response to bath application of the α1-adrenergic receptor
agonist phenylnephrine, mimicking the excitatory drive of
norepinephrine on raphe 5-HT neurons in the intact brain
(Judge and Gartside, 2006). Additionally, dorsal raphe 5-HT
neurons were identiﬁed through their well-described sensitivity
to the 5-HT1A receptor agonist 8-OH-DPAT (Nomikos et al.,
1996; Evrard et al., 1999). In this eﬀort, we obtained evidence
for a signiﬁcantly reduced basal ﬁring rate of DRN 5-HT
neurons in Nlgn2 null mice compared to the neurons of
WT littermates (Figure 7A). These eﬀects could relate to
an intrinsic reduction in dorsal raphe neuron excitability or
to a reduced eﬃcacy of noradrenergic signaling to ﬁring-
regulatory K+ channels (Karschin et al., 1991). To explore
this issue further, we used single-cell patch-clamp recordings
to evaluate cell excitability independent of synaptic input and
to assess GABAergic and 5-HT1A mediated inhibitory inputs.
To further insure correct identiﬁcation of 5-HT neurons, we
bred Nlgn2 null mice with a reporter strain that expresses
YFP under the control of Tph2 promoter (Zhao et al.,
2011). Current injections were used to drive ﬁring of dorsal
raphe neurons. As with phenylnephrine-stimulated ﬁring, we
found current injections into dorsal raphe 5-HT neurons to
exhibit a reduced ﬁring frequency (Figure 7B). We also used
this recording format to evaluate changes in GABA- and 5-
HT-mediated inhibitory responses. We observed signiﬁcantly
reduced GABAA receptor-mediated IPSCs in NLGN2 null slices
compared to slices of WT littermates, with reductions evident
in both amplitude and frequency (Figures 8A,B). In contrast,
FIGURE 4 | Nlgn2 null mice exhibit a midbrain-specific reduction in SERT expression. Western blots of SERT protein in (A) midbrain and (B) hippocampus.
NLGN2 protein levels are not different between SERT null mice and their WT littermates in midbrain (C) or hippocampus (D). For (A) ∗∗∗P = 0.001, one-way ANOVA;
∗∗P < 0.01 for WT vs. null and ∗P < 0.05 for HET vs. null, Bonferroni’s Multiple Comparison Test, N = 5 for each genotype. For (B) P = 0.003, one-way ANOVA;
∗P < 0.05 for WT vs. HET and WT vs. null, Bonferroni’s Multiple Comparison Test. N = 5 for each genotype.
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FIGURE 5 | Loss of NLGN2 expression does not impact steady state 5-HT homeostasis. Mice have normal midbrain 5-HT levels and 5-HT turnover ratios
(A,B, N = 11 for WT and N = 9 for null), as well as GABA levels and glutamate/GABA ratios (C,D, N = 8 for WT and N = 5 for null). P > 0.05, Student’s t-test.
FIGURE 6 | Nlgn2 null mice exhibit decreased midbrain 5-HT synaptosomal uptake. (A) Substrate concentration [5-HT] = 50 nM (∗∗P < 0.01 for midbrain,
NS for hippocampus, N = 6 for each genotype, Student’s t-test); (B) Substrate concentration [5-HT] = 1 μM (∗∗P < 0.01 for midbrain, ∗P < 0.05 for hippocampus,
N = 4 for each genotype, Student’s t-test).
dorsal raphe 5-HT neurons displayed an increased eﬃcacy
of 5-HT1A receptors, captured as an increase in membrane
hyperpolarization achieved with a saturating agonist (8-OH-
DPAT) concentration (Figure 8C).
Nlgn2 Null Mice Exhibit Altered
Behaviors in Tests Associated with 5-HT
Signaling through SERT and 5-HT
Receptors
Nlgn2 null mice have been assessed in multiple behavioral tests
and found to demonstrate phenotypes suggestive of anxiety
(Blundell et al., 2009; Wohr et al., 2013; Babaev et al.,
2015) or autism spectrum disorder (ASD; Hines et al., 2008;
Kohl et al., 2015; Liang et al., 2015). Owing to the changes
observed in the Nlgn2 null mice in SERT expression and
DRN electrophysiological properties, we sought to determine
whether these animals would also display changes in behaviors
sensitive to pharmacological or genetic SERT manipulation.
Reduced immobility in the tail suspension test (TST) and forced
swim test (FST) arise in animals with antidepressant-induced
blockade of SERT (Holmes et al., 2002). As Nlgn2 null mice
have reduced SERT levels, and we therefore predicted that
these mice might display a phenotype similar to that seen with
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FIGURE 7 | Changes in dorsal raphe neuron firing rates in Nlgn2 null mice. (A) Reduced basal firing rates of 5-HT neurons in dorsal raphe nucleus in
multi-electrode array recordings (∗P < 0.05, N = 7 animals and 23 cells for each genotype, Student’s t-test). (B) Reduced firing rates following +50 pA current
injection in whole-cell current clamp of dorsal raphe 5-HT neurons (∗P < 0.05, N = 8 cells for WT and 10 cells for null, Student’s t-test).
SSRI treatment. Indeed, Nlgn2 null mice displayed signiﬁcantly
reduced immobility time compared to their WT littermate
controls, with the most striking reduction evident in the TST
(Figures 9A,B). SERT null mice (Rioux et al., 1999; Li et al.,
2003) display reduced 5-HT2A receptor expression/sensitivity,
presumably arising from elevated tonic extracellular 5-HT
exposure. Consistent with these ﬁndings, when we queried
the sensitivity of post-synaptic 5-HT2A receptors via the DOI-
induced head twitching assays, we found thatNlgn2 null mice had
signiﬁcantly reduced responses compared toWTmice, consistent
with diminished or desensitized 5-HT2A receptors (Figure 9C).
Recently, we have shown that social dominance in the tube
test is impacted by expression of an autism-associated SERT
coding variant (Veenstra-VanderWeele et al., 2012), and SERT
null mice demonstrate reduced social dominance (Lewejohann
et al., 2010). Although other tests have demonstrated typical
social behaviors in other paradigms, in the Nlgn2 null mice, we
found these animals to also exhibit a signiﬁcantly higher tendency
to withdraw from the tube when encountering a WT mouse
(Figure 9D).
DISCUSSION
Our work brings to light the existence of a novel SERT-associated
protein complex, one that our biochemical and imaging studies
indicates is speciﬁcally associated with the somatodendritic
compartment of dorsal raphe 5-HT neurons and that contains
the synaptic adhesion protein NLGN2. NLGN2 is one member of
a family of homologous, synaptic cell adhesion proteins (NLGNs
1–4) that form trans-synaptic interactions with presynaptic
neurexin (NRXN) proteins. NLGN2 has been consistently found
to localized to the post-synaptic side of inhibitory, GABAergic
synapses (Graf et al., 2004) as well as a subset of glycinergic
synapses (Poulopoulos et al., 2009). A recent electron microscopy
immunocytochemical study reported that NLGN2 also exists
post-synaptic to cholinergic terminals in the CNS (Takacs et al.,
2013). Although we cannot exclude potential interactions of
SERT with cholinergic receptor complexes, we obtained evidence
in our proteomic and SERT co-immunoprecipitation studies
for multiple proteins linked to the function of GABAergic
inhibitory signaling, including collybistin and GABAA receptors,
and thus we believe our SERT:NLGN2 ﬁndings speak to
physical proximity and interactions of SERT with determinants
of GABAergic modulation of dorsal raphe excitability. Local
GABAergic interneurons provide signiﬁcant inhibitory control
of dorsal raphe ﬁring and these neurons receive extensive
descending inputs, for example from the medial prefrontal cortex
(Celada et al., 2001; Srejic et al., 2015). GABAergic interneurons
provide a path through which drugs of abuse including opiates
(Tao and Auerbach, 2002) and nicotine (Hernandez-Vazquez
et al., 2014) can modulate raphe 5-HT neuron output. Projection
neurons, for example from the striatum, also innervate dorsal
raphe neurons (Pollak Dorocic et al., 2014; Weissbourd et al.,
2014). Several subunits of GABAA receptors, including alpha1–
3, were found to be highly expressed by raphe 5-HT neurons
(Corteen et al., 2015). The role of NLGN2 as an inhibitory post-
synaptic cell adhesion protein that can facilitate organization of
GABAA receptor complexes is consistent with our ﬁnding of a
dramatic loss of 5-HT neuron GABAergic IPSCs in Nlgn2 null
mice.
Nature of the SERT:NLGN2 Complex
Using reciprocal co-immunoprecipitation experiments with
SERT and NLGN2 antibodies in WT and null mice, we
demonstrate speciﬁcity of protein associations. Although DAT
and NET can be readily detected in midbrain extracts, no
associations with NLGN2 were obtained, revealing a unique
relationship with SERT-dependent signaling. Consistent with
this ﬁnding, we also observed no signiﬁcant correlation
between Nlgn2 and DAT mRNA (Ye et al., 2014a,b). SERT
is synthesized in the somatic comparted and exported for
expression on both somatodendritic and axonal membranes
(Tao-Cheng and Zhou, 1999; Descarries and Riad, 2012). We
observed SERT and NLGN2 immunoreactivity localized to
raphe cell bodies whereas SERT-positive axonal proﬁles in
the surrounding neuropil were NLGN2-negative, suggesting
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FIGURE 8 | Altered 5-HT neuron modulation by GABA and 5-HT inputs
in Nlgn2 null mice. Nlgn2 null mice exhibit reduced GABAA-mediated,
gabazine-sensitive sIPSCs, in both (A) inter-event interval (P < 0.001,
D = 0.4851, N = 5 cells for WT and six cells for null, Kolmogorov–Smirnov
test) and (B) amplitude (P < 0.001, D = 0.5392, N = 5 cells for WT and six
cells for null, Kolmogorov–Smirnov test). (C) Nlgn2 null mice showed
enhanced 5-HT1A receptor agonist (8-OH-DPAT)-induced hyperpolarization
(∗∗P < 0.01, N = 11 cells for WT and seven cells for null, Student’s t-test).
that the SERT:NLGN2 complex is a feature of the dorsal
raphe somatodendritic membrane. Consistent with this idea, we
could not recover SERT:NLGN2 complexes from hippocampal
extracts, despite signiﬁcant recovery of each protein individually,
nor do we recover SERT:NLGN2 complexes eﬃciently from
synaptosomes vs. intact tissue preparations. Although the
source of 5-HT input is debated (Bagdy et al., 1998; Colgan
et al., 2012; Mlinar et al., 2015), somatodendritic SERT
proteins likely work in concert with axonal SERTs to limit
feedback inhibition of raphe neurons by 5-HT1A autoreceptors
(Blier et al., 1998). A somatodendritic SERT:NLGN2 complex
implies interactions of the two proteins in cis, vs. a trans
conﬁguration that would apply if axonal SERT interacted with
post-synaptic NLGN2 via the intermediary of a cis NRXN
interaction. Additionally, we found SERT:NLGN2 complexes to
be insensitive to Ca2+ chelation, whereas recovery of α-NRXN
from SERT immunoprecipitations was lost. Thus, recovery
of NRXN proteins with SERT immunoprecipitations is likely
an indirect consequence of Ca2+ independent associations
SERT makes with NLGN2. Recovery of α-NRXN in SERT
co-immunoprecipitations also indicates that the SERT:NLGN2
complex is unlikely to represent a transient, intracellular complex
that disperses upon sorting of transporter to plasma membrane
domains, though higher resolution localization methods are
needed to fully resolve this issue and can provide information
as to whether SERT forms a complex with NLGN2 early during
synthesis and export to the plasma membrane. Although we
do not know whether the SERT:NLGN2 interaction is direct,
our preliminary experiments indicate that the two proteins
can be co-immunoprecipitated from co-transfected HEK-293
cells, suggesting that no neuron-speciﬁc scaﬀolding proteins
are required to support the interaction. Further studies with
the latter system, as well as candidate interacting domains
in vitro, are needed to deﬁne key structural elements that support
SERT:NLGN2 interactions and allow for a further dissection of
their functional signiﬁcance.
SERT Expression Levels are
NLGN2-Dependent
Changes in the levels of major synaptic proteins in the Nlgn2 null
mice have previously been proﬁled (Blundell et al., 2009). At the
whole brain level, elimination of Nlgn2 expression does not cause
signiﬁcant changes in the expression of proteins that are essential
for glutamate and GABA actions at pre- or post-synaptic sites.
Thus we were surprised to ﬁnd a strong positive correlation for
mRNA levels of Nlgn2 and Slc6a4 in the midbrain of BXD mice.
Consistent with these ﬁndings, we found that SERT proteins are
signiﬁcantly down-regulated in the Nlgn2 null midbrain, with
intermediate eﬀects observed in Nlgn2+/− animals. As these
eﬀects did not arise in the context of a commensurate loss of 5-
HT neurons or 5-HT levels, they do not derive from an impact
of NLGN2 on raphe neuron viability. We also observed no loss
of NLGN2 levels in Slc6a4 null mice, although the fraction of
NLGN2 in 5-HT neurons is likely but a small fraction of midbrain
expression. Thus, although NLGN2 may impact the stability and
export of SERT proteins, it is possible that the correlation of
Slc6a4 and Nlgn2 mRNA and the loss of SERT protein in Nlgn2
null mice derive from a disruption of GABAergic (and possibly
cholinergic) synaptic input to 5-HT neurons. In this regard,
Lukkes et al. (2013) observed decreased Tph2 mRNA expression
with treatment of mice with anxiogenic GABAA inverse agonist
treatment, though this short-term treatment (4 h) was insuﬃcient
to impact SERT mRNA levels. We also demonstrated a change
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FIGURE 9 | Altered behavior of Nlgn2 null mice. Nlgn2 null are (A) less immobile in the tail suspension (∗∗∗P < 0.001; N = 12 for each genotype, Student’s
t-test) and (B) forced swim test (∗∗P < 0.01; N = 10 for each genotype, Student’s t-test), (C) have fewer head twitches after 5-HT2A/2C agonist (DOI) injection
(∗P < 0.05; N = 6 for each genotype, Student’s t-test), and (D) back out more in the tube test (∗∗∗P < 0.001; N = 12 for each genotype, McNemar’s test) compared
to WT littermates.
in intrinsic excitability of serotonergic dorsal raphe neurons in
Nlgn2 null mice indicating changes in the machinery supporting
expression of other ion channels whose identity we have yet
to pursue. Finally, it is possible that the relationship between
Nlgn2 and Slc6a4 may be non-cell autonomous, derived from
GABAergic modulation of other projections that impinge on 5-
HT neurons. In this regard, conditional elimination of Nlgn2
has been achieved (Liang et al., 2015), providing a path to
determining whether the levels of NLGN2 in 5-HT neurons are
directly connected to these ﬁndings.
DRN 5-HT Neuron Excitability is Altered
in NLGN2 Null Mice
The ﬁring of DRN 5-HT neurons is under control of extrinsic
glutamatergic, GABAergic, noradrenergic, and peptidergic inputs
(Soiza-Reilly et al., 2013; Weissbourd et al., 2014), as well as
intrinsic 5-HT auto-regulation (Blier et al., 1998). As expected,
a direct consequence of loss of NLGN2 in 5-HT neurons was
a signiﬁcant reduction in GABAergic IPSCs. The reduction we
observe in IPSC amplitude indicates either a desensitization
or down-regulation of GABAA receptors, consistent with the
function of NLGN2 in organizing GABAergic post-synaptic
protein complexes (Graf et al., 2004). Similar eﬀects were also
observed in pyramidal neurons from the barrel cortex of NLGN2
null mice (Gibson et al., 2009). Interestingly, the frequency of
the spontaneous IPSCs is also reduced in the NLGN2 null mice,
suggesting a decrease in GABA release from presynaptic vesicles.
This eﬀect may arise from compensatory changes in presynaptic
GABAergic terminals communicated through unliganded NRXN
proteins. Alternatively, the change in frequency may result from
a dispersal of post-synaptic GABAA receptors, reducing the
probability that vesicles will be opposed to suﬃcient receptors to
mediate an IPSC response. We also observed changes in DRN
5-HT1A receptor sensitivity in the Nlgn2 nulls. Reductions in
SERT levels that arise in the Nlgn2 null mice could allow for
increased stimulation of 5-HT1A receptors by extracellular 5-
HT and increased feedback inhibition. Slc6a4 null mice display
a reduction in the expression of dorsal raphe 5HT1A receptors
(Fabre et al., 2000; Li et al., 2000), though more recent work
indicates that compensatory mechanisms are engaged to sustain
autoreceptor-mediated inhibition (Araragi et al., 2013). How
the SERT:NLGN2 complex supports or limits the transporter’s
ability to limit 5-HT1A activation will require the development
of tools (e.g., interfering peptides) that can disrupt this complex
without inducing other changes attendant to a loss of NLGN2
levels. Regardless, NLGN2 appears to be physically poised to play
a signiﬁcant role in coordinating the balance of intrinsic and
extrinsic inhibitory control of dorsal raphe 5-HT neurons.
Potential Translational Relevance of
Serotonergic Expression of NLGN2
Rare variation in NLGN2 has been identiﬁed in subjects with
schizophrenia (Sun et al., 2011). A 17p13.1 duplication that
harbors the NLGN2 gene has been observed in individuals
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with intellectual disability (Belligni et al., 2012; Kuroda
et al., 2014; Mooneyham et al., 2014). NLGN2 null and
overexpressing mice exhibit multiple traits thought to mimic
ASD, including communication deﬁcits, as revealed by
reduced ultrasonic vocalizations, repetitive behaviors and
impaired social interactions (Hines et al., 2008; Blundell et al.,
2009; Wohr et al., 2013). Although NLGN2 is expressed
throughout the CNS, changes in 5-HT and SERT have
been implicated in these disorders as well (Hranilovic et al.,
2000; Ozaki et al., 2003; Prasad et al., 2009; Blasi et al.,
2013), and our current studies raise the possibility that
components of behavioral deﬁcits observed in preclinical
models and humans with NLGN2 mutations may derive
from compromised 5-HT signaling. The presence of SERT
in NLGN2 complexes unique to raphe neurons vs. axonal
projections raises the possibility of targeting this subset of
transporters pharmacologically with potentially unique clinical
beneﬁt.
CONCLUSION
Disrupted 5-HT signaling has been associated with many
neuropsychiatric disorders including depression, OCD and
autism. SERT proteins govern the rate and extent of 5-HT
clearance and are organized in the plasma membrane as multi-
protein complexes. We have identiﬁed a unique interaction
between SERT and the trans-synaptic adhesion protein NLGN2,
with evidence that this interaction arises speciﬁcally in raphe 5-
HT somatodendritic elements and involves other components
of GABAergic inhibitory signaling. Along with evidence that
NLGN2 protein levels dictate SERT expression levels, the
presence of the SERT:NLGN2 complex reinforces a close
relationship between GABAergic signaling mechanisms and
biochemical, cellular, and behavioral phenotypes associated with
5-HT neurons.
AUTHOR CONTRIBUTIONS
RY and RB conceived project. RY, MQ, HI, H-HW, NG, CJ, DM,
JV-V, PL, and RB designed experiments. RY, MQ, HI, H-HW,
NG, and CJ performed experiments. RY, MQ, HI, H-HW, NG,
CJ, DM, JV-V, PL, and RB analyzed data. RY, MQ, and RB
wrote the paper. All authors commented and contributed to the
manuscript.
ACKNOWLEDGMENTS
RB gratefully acknowledges support for the research from
the National Institutes of Health (MH094527 and MH096972)
and Vanderbilt Digestive Disease Research Center grant No.
P30DK058404. RY acknowledges support from CTSA award
No. UL1TR000445 from the National Center for Advancing
Translational Sciences (RY) and a pilot grant from the Vanderbilt
Silvio O. Conte Center. The authors thank Chris Svitek, Jane
Wright, Angela Steele, Tracy Moore-Jarrett, and Qiao Han for
excellent laboratory management and technical assistance.
SUPPLEMENTARY MATERIAL
The Supplementary Material for this article can be found
online at: http://journal.frontiersin.org/article/10.3389/fnsyn.
2015.00020
REFERENCES
Abrams, J. K., Johnson, P. L., Hollis, J. H., and Lowry, C. A. (2004). Anatomic and
functional topography of the dorsal raphe nucleus. Ann. N. Y. Acad. Sci. 1018,
46–57. doi: 10.1196/annals.1296.005
Arac, D., Boucard, A. A., Ozkan, E., Strop, P., Newell, E., Sudhof, T. C., et al. (2007).
Structures of neuroligin-1 and the neuroligin-1/neurexin-1 beta complex reveal
speciﬁc protein-protein and protein-Ca2+ interactions. Neuron 56, 992–1003.
doi: 10.1016/j.neuron.2007.12.002
Araragi, N., Mlinar, B., Baccini, G., Gutknecht, L., Lesch, K. P., and Corradetti, R.
(2013). Conservation of 5-HT1A receptor-mediated autoinhibition of serotonin
(5-HT) neurons inmice with altered 5-HT homeostasis. Front. Pharmacol. 4:97.
doi: 10.3389/fphar.2013.00097
Audero, E., Mlinar, B., Baccini, G., Skachokova, Z. K., Corradetti, R., and Gross, C.
(2013). Suppression of serotonin neuron ﬁring increases aggression in mice.
J. Neurosci. 33, 8678–8688. doi: 10.1523/JNEUROSCI.2067-12.2013
Azmitia, E. C. (2007). Serotonin and brain: evolution, neuroplasticity, and
homeostasis. Int. Rev. Neurobiol. 77, 31–56. doi: 10.1016/S0074-7742(06)
77002-7
Babaev, O., Botta, P., Meyer, E., Muller, C., Ehrenreich, H., Brose, N., et al.
(2015). Neuroligin 2 deletion alters inhibitory synapse function and anxiety-
associated neuronal activation in the amygdala.Neuropharmacology 100, 56–65.
doi: 10.1016/j.neuropharm.2015.06.016
Bagdy, E., Solyom, S., and Harsing, L. G. Jr. (1998). Feedback stimulation of
somatodendritic serotonin release: a 5-HT3 receptor-mediated eﬀect in the
raphe nuclei of the rat. Brain Res. Bull. 45, 203–208. doi: 10.1016/S0361-
9230(97)00340-7
Baudry, A., Mouillet-Richard, S., Schneider, B., Launay, J. M., and Kellermann, O.
(2010). miR-16 targets the serotonin transporter: a new facet for
adaptive responses to antidepressants. Science 329, 1537–1541. doi:
10.1126/science.1193692
Bauman, A. L., Apparsundaram, S., Ramamoorthy, S., Wadzinski, B. E., Vaughan,
R. A., and Blakely, R. D. (2000). Cocaine and antidepressant-sensitive biogenic
amine transporters exist in regulated complexes with protein phosphatase 2A.
J. Neurosci. 20, 7571–7578.
Beck, S. G., Pan, Y. Z., Akanwa, A. C., and Kirby, L. G. (2004). Median and
dorsal raphe neurons are not electrophysiologically identical. J. Neurophysiol.
91, 994–1005. doi: 10.1152/jn.00744.2003
Belligni, E. F., Di Gregorio, E., Biamino, E., Calcia, A., Molinatto, C.,
Talarico, F., et al. (2012). 790 Kb microduplication in chromosome band
17p13.1 associated with intellectual disability, afebrile seizures, dysmorphic
features, diabetes, and hypothyroidism. Eur. J. Med. Genet. 55, 222–224. doi:
10.1016/j.ejmg.2012.01.016
Blasi, G., De Virgilio, C., Papazacharias, A., Taurisano, P., Gelao, B., Fazio, L.,
et al. (2013). Converging evidence for the association of functional
genetic variation in the serotonin receptor 2a gene with prefrontal
function and olanzapine treatment. JAMA Psychiatry 70, 921–930. doi:
10.1001/jamapsychiatry.2013.1378
Blier, P., Pineyro, G., el Mansari, M., Bergeron, R., and de Montigny, C.
(1998). Role of somatodendritic 5-HT autoreceptors in modulating 5-HT
neurotransmission. Ann. N. Y. Acad. Sci. 861, 204–216. doi: 10.1111/j.1749-
6632.1998.tb10192.x
Blundell, J., Tabuchi, K., Bolliger, M. F., Blaiss, C. A., Brose, N., Liu, X., et al.
(2009). Increased anxiety-like behavior in mice lacking the inhibitory synapse
Frontiers in Synaptic Neuroscience | www.frontiersin.org 14 January 2016 | Volume 7 | Article 20
Ye et al. Neuroligin 2 Interactions with the Serotonin Transporter
cell adhesion molecule neuroligin 2. Genes Brain Behav. 8, 114–126. doi:
10.1111/j.1601-183X.2008.00455.x
Bunin, M. A., and Wightman, R. M. (1998). Quantitative evaluation of 5-
hydroxytryptamine (serotonin) neuronal release and uptake: an investigation
of extrasynaptic transmission. J. Neurosci. 18, 4854–4860.
Carneiro, A. M., and Blakely, R. D. (2006). Serotonin-, protein kinase C-, and Hic-
5-associated redistribution of the platelet serotonin transporter. J. Biol. Chem.
281, 24769–24780. doi: 10.1074/jbc.M603877200
Carneiro, A. M., Cook, E. H., Murphy, D. L., and Blakely, R. D. (2008).
Interactions between integrin alphaIIbbeta3 and the serotonin transporter
regulate serotonin transport and platelet aggregation in mice and humans.
J. Clin. Invest. 118, 1544–1552. doi: 10.1172/JCI33374
Celada, P., Puig, M. V., Casanovas, J. M., Guillazo, G., and Artigas, F. (2001).
Control of dorsal raphe serotonergic neurons by the medial prefrontal cortex:
involvement of serotonin-1A, GABA(A), and glutamate receptors. J. Neurosci.
21, 9917–9929.
Chanrion, B., Mannoury la Cour, C., Bertaso, F., Lerner-Natoli, M., Freissmuth, M.,
Millan, M. J., et al. (2007). Physical interaction between the serotonin
transporter and neuronal nitric oxide synthase underlies reciprocal modulation
of their activity. Proc. Natl. Acad. Sci. U.S.A. 104, 8119–8124. doi:
10.1073/pnas.0610964104
Chen, Y. C., Lin, Y. Q., Banerjee, S., Venken, K., Li, J., Ismat, A., et al. (2012).
Drosophila neuroligin 2 is required presynaptically and postsynaptically for
proper synaptic diﬀerentiation and synaptic transmission. J. Neurosci. 32,
16018–16030. doi: 10.1523/JNEUROSCI.1685-12.2012
Clements, J. D., and Bekkers, J. M. (1997). Detection of spontaneous synaptic
events with an optimally scaled template. Biophys. J. 73, 220–229. doi:
10.1016/S0006-3495(97)78062-7
Colgan, L. A., Cavolo, S. L., Commons, K. G., and Levitan, E. S. (2012).
Action potential-independent and pharmacologically unique vesicular
serotonin release from dendrites. J. Neurosci. 32, 15737–15746. doi:
10.1523/JNEUROSCI.0020-12.2012
Corteen, N. L., Carter, J. A., Rudolph, U., Belelli, D., Lambert, J. J., and Swinny, J. D.
(2015). Localisation and stress-induced plasticity of GABAA receptor subunits
within the cellular networks of the mouse dorsal raphe nucleus. Brain Struct.
Funct. 220, 2739–2763. doi: 10.1007/s00429-014-0824-7
Descarries, L., and Riad, M. (2012). Eﬀects of the antidepressant ﬂuoxetine on the
subcellular localization of 5-HT1A receptors and SERT. Philos. Trans. R. Soc.
Lond. B Biol. Sci. 367, 2416–2425. doi: 10.1098/rstb.2011.0361
Evrard, A., Laporte, A. M., Chastanet, M., Hen, R., Hamon, M., and Adrien, J.
(1999). 5-HT1A and 5-HT1B receptors control the ﬁring of serotoninergic
neurons in the dorsal raphe nucleus of the mouse: studies in 5-HT1B knock-out
mice. Eur. J. Neurosci. 11, 3823–3831. doi: 10.1046/j.1460-9568.1999.00800.x
Fabre, V., Beaufour, C., Evrard, A., Rioux, A., Hanoun, N., Lesch, K. P., et al.
(2000). Altered expression and functions of serotonin 5-HT1A and 5-HT1B
receptors in knock-out mice lacking the 5-HT transporter. Eur. J. Neurosci. 12,
2299–2310. doi: 10.1046/j.1460-9568.2000.00126.x
Gaspar, P., and Lillesaar, C. (2012). Probing the diversity of serotonin
neurons. Philos. Trans. R. Soc. Lond. B Biol. Sci. 367, 2382–2394. doi:
10.1098/rstb.2011.0378
Gauthier, J., Siddiqui, T. J., Huashan, P., Yokomaku, D., Hamdan, F. F.,
Champagne, N., et al. (2011). Truncating mutations in NRXN2 and NRXN1
in autism spectrum disorders and schizophrenia. Hum. Genet. 130, 563–573.
doi: 10.1007/s00439-011-0975-z
Gibson, J. R., Huber, K. M., and Sudhof, T. C. (2009). Neuroligin-2 deletion
selectively decreases inhibitory synaptic transmission originating from fast-
spiking but not from somatostatin-positive interneurons. J. Neurosci. 29,
13883–13897. doi: 10.1523/JNEUROSCI.2457-09.2009
Graf, E. R., Zhang, X., Jin, S. X., Linhoﬀ,M.W., and Craig, A. M. (2004). Neurexins
induce diﬀerentiation of GABA and glutamate postsynaptic specializations via
neuroligins. Cell 119, 1013–1026. doi: 10.1016/j.cell.2004.11.035
Green, N. H., Jackson, C. R., Iwamoto, H., Tackenberg, M. C., and McMahon, D. G.
(2015). Photoperiod programs dorsal raphe serotonergic neurons and aﬀective
behaviors. Curr. Biol. 25, 1389–1394. doi: 10.1016/j.cub.2015.03.050
Hensler, J. G., Ferry, R. C., Labow, D. M., Kovachich, G. B., and Frazer, A.
(1994). Quantitative autoradiography of the serotonin transporter to assess the
distribution of serotonergic projections from the dorsal raphe nucleus. Synapse
17, 1–15. doi: 10.1002/syn.890170102
Hernandez-Vazquez, F., Chavarria, K., Garduno, J., Hernandez-Lopez, S., and
Mihailescu, S. P. (2014). Nicotine increases GABAergic input on rat dorsal
raphe serotonergic neurons through alpha7 nicotinic acetylcholine receptor.
J. Neurophysiol. 112, 3154–3163. doi: 10.1152/jn.00223.2014
Hines, R. M., Wu, L., Hines, D. J., Steenland, H., Mansour, S., Dahlhaus, R., et al.
(2008). Synaptic imbalance, stereotypies, and impaired social interactions in
mice with altered neuroligin 2 expression. J. Neurosci. 28, 6055–6067. doi:
10.1523/JNEUROSCI.0032-08.2008
Holmes, A., Yang, R. J., Murphy, D. L., and Crawley, J. N. (2002). Evaluation
of antidepressant-related behavioral responses in mice lacking the serotonin
transporter. Neuropsychopharmacology 27, 914–923. doi: 10.1016/S0893-
133X(02)00374-3
Homberg, J. R., and Lesch, K. P. (2011). Looking on the bright side of
serotonin transporter gene variation. Biol. Psychiatry 69, 513–519. doi:
10.1016/j.biopsych.2010.09.024
Hranilovic, D., Schwab, S. G., Jernej, B., Knapp, M., Lerer, B., Albus, M.,
et al. (2000). Serotonin transporter gene and schizophrenia: evidence for
association/linkage disequilibrium in families with aﬀected siblings. Mol.
Psychiatry 5, 91–95. doi: 10.1038/sj.mp.4000599
Ichtchenko, K., Nguyen, T., and Sudhof, T. C. (1996). Structures, alternative
splicing, and neurexin binding of multiple neuroligins. J. Biol. Chem. 271,
2676–2682. doi: 10.1074/jbc.271.5.2676
Jennings, K. A., Loder,M. K., Sheward,W. J., Pei, Q., Deacon, R. M., Benson,M. A.,
et al. (2006). Increased expression of the 5-HT transporter confers a low-anxiety
phenotype linked to decreased 5-HT transmission. J. Neurosci. 26, 8955–8964.
doi: 10.1523/JNEUROSCI.5356-05.2006
Judge, S. J., and Gartside, S. E. (2006). Firing of 5-HT neurones in the dorsal
and median raphe nucleus in vitro shows diﬀerential alpha1-adrenoceptor
and 5-HT1A receptor modulation. Neurochem. Int. 48, 100–107. doi:
10.1016/j.neuint.2005.09.003
Karschin, A., Ho, B. Y., Labarca, C., Elroy-Stein, O., Moss, B., Davidson, N.,
et al. (1991). Heterologously expressed serotonin 1A receptors couple to
muscarinic K+ channels in heart. Proc. Natl. Acad. Sci. U.S.A. 88, 5694–5698.
doi: 10.1073/pnas.88.13.5694
Koehnke, J., Jin, X., Budreck, E. C., Posy, S., Scheiﬀele, P., Honig, B., et al.
(2008). Crystal structure of the extracellular cholinesterase-like domain
from neuroligin-2. Proc. Natl. Acad. Sci. U.S.A. 105, 1873–1878. doi:
10.1073/pnas.0711701105
Kohl, C., Wang, X. D., Grosse, J., Fournier, C., Harbich, D., Westerholz, S., et al.
(2015). Hippocampal neuroligin-2 links early-life stress with impaired social
recognition and increased aggression in adult mice. Psychoneuroendocrinology
55, 128–143. doi: 10.1016/j.psyneuen.2015.02.016
Kuroda, Y., Ohashi, I., Tominaga, M., Saito, T., Nagai, J., Ida, K., et al. (2014). De
novo duplication of 17p13.1-p13.2 in a patient with intellectual disability and
obesity. Am. J. Med. Genet. A 164A, 1550–1554. doi: 10.1002/ajmg.a.36477
Lau, T., Schneidt, T., Heimann, F., Gundelﬁnger, E. D., and Schloss, P.
(2010). Somatodendritic serotonin release and re-uptake in mouse embryonic
stem cell-derived serotonergic neurons. Neurochem. Int. 57, 969–978. doi:
10.1016/j.neuint.2010.10.003
Lesch, K. P., Bengel, D., Heils, A., Sabol, S. Z., Greenberg, B. D., Petri, S.,
et al. (1996). Association of anxiety-related traits with a polymorphism in
the serotonin transporter gene regulatory region. Science 274, 1527–1531. doi:
10.1126/science.274.5292.1527
Lewejohann, L., Kloke, V., Heiming, R. S., Jansen, F., Kaiser, S., Schmitt, A., et al.
(2010). Social status and day-to-day behaviour of male serotonin transporter
knockout mice. Behav. Brain Res. 211, 220–228. doi: 10.1016/j.bbr.2010.03.035
Li, Q., Wichems, C., Heils, A., Lesch, K. P., and Murphy, D. L. (2000). Reduction in
the density and expression, but not G-protein coupling, of serotonin receptors
(5-HT1A) in 5-HT transporter knock-out mice: gender and brain region
diﬀerences. J. Neurosci. 20, 7888–7895.
Li, Q., Wichems, C. H., Ma, L., Van de Kar, L. D., Garcia, F., and Murphy, D. L.
(2003). Brain region-speciﬁc alterations of 5-HT2A and 5-HT2C receptors
in serotonin transporter knockout mice. J. Neurochem. 84, 1256–1265. doi:
10.1046/j.1471-4159.2003.01607.x
Liang, J., Xu, W., Hsu, Y. T., Yee, A. X., Chen, L., and Sudhof, T. C.
(2015). Conditional neuroligin-2 knockout in adult medial prefrontal cortex
links chronic changes in synaptic inhibition to cognitive impairments. Mol.
Psychiatry 20, 850–859. doi: 10.1038/mp.2015.31
Frontiers in Synaptic Neuroscience | www.frontiersin.org 15 January 2016 | Volume 7 | Article 20
Ye et al. Neuroligin 2 Interactions with the Serotonin Transporter
Lukkes, J. L., Kopelman, J. M., Donner, N. C., Hale, M.W., and Lowry, C. A. (2013).
Development x environment interactions control tph2 mRNA expression.
Neuroscience 237, 139–150. doi: 10.1016/j.neuroscience.2013.01.070
Mathews, T. A., Fedele, D. E., Coppelli, F. M., Avila, A. M., Murphy,
D. L., and Andrews, A. M. (2004). Gene dose-dependent alterations
in extraneuronal serotonin but not dopamine in mice with reduced
serotonin transporter expression. J. Neurosci. Methods 140, 169–181. doi:
10.1016/j.jneumeth.2004.05.017
Mlinar, B., Montalbano, A., Baccini, G., Tatini, F., Berlinguer Palmini, R.,
and Corradetti, R. (2015). Nonexocytotic serotonin release tonically
suppresses serotonergic neuron activity. J. Gen. Physiol. 145, 225–251.
doi: 10.1085/jgp.201411330
Montanez, S., Owens, W. A., Gould, G. G., Murphy, D. L., and Daws,
L. C. (2003). Exaggerated eﬀect of ﬂuvoxamine in heterozygote serotonin
transporter knockout mice. J. Neurochem. 86, 210–219. doi: 10.1046/j.1471-
4159.2003.01836.x
Mooneyham, K. A., Holden, K. R., Cathey, S., Dwivedi, A., Dupont, B. R., and
Lyons, M. J. (2014). Neurodevelopmental delays and macrocephaly in 17p13.1
microduplication syndrome. Am. J. Med. Genet. A 164A, 2887–2891. doi:
10.1002/ajmg.a.36708
Nguyen, T., and Sudhof, T. C. (1997). Binding properties of neuroligin 1 and
neurexin 1beta reveal function as heterophilic cell adhesion molecules. J. Biol.
Chem. 272, 26032–26039. doi: 10.1074/jbc.272.41.26032
Nomikos, G. G., Arborelius, L., Hook, B. B., Hacksell, U., and Svensson, T. H.
(1996). The 5-HT1A receptor antagonist (S)-UH-301 decreases dopamine
release in the rat nucleus accumbens and striatum. J. Neural Transm. 103,
541–554. doi: 10.1007/BF01273152
Ozaki, N., Goldman, D., Kaye, W. H., Plotnicov, K., Greenberg, B. D.,
Lappalainen, J., et al. (2003). Serotonin transporter missense mutation
associated with a complex neuropsychiatric phenotype. Mol. Psychiatry 8,
933–936. doi: 10.1038/sj.mp.4001415
Panzanelli, P., Gunn, B. G., Schlatter, M. C., Benke, D., Tyagarajan, S. K.,
Scheiﬀele, P., et al. (2011). Distinct mechanisms regulate GABAA receptor and
gephyrin clustering at perisomatic and axo-axonic synapses on CA1 pyramidal
cells. J. Physiol. 589, 4959–4980. doi: 10.1113/jphysiol.2011.216028
Pollak Dorocic, I., Furth, D., Xuan, Y., Johansson, Y., Pozzi, L., Silberberg, G., et al.
(2014). A whole-brain atlas of inputs to serotonergic neurons of the dorsal
and median raphe nuclei. Neuron 83, 663–678. doi: 10.1016/j.neuron.2014.
07.002
Poulopoulos, A., Aramuni, G., Meyer, G., Soykan, T., Hoon, M., Papadopoulos, T.,
et al. (2009). Neuroligin 2 drives postsynaptic assembly at perisomatic
inhibitory synapses through gephyrin and collybistin.Neuron 63, 628–642. doi:
10.1016/j.neuron.2009.08.023
Prasad, H. C., Steiner, J. A., Sutcliﬀe, J. S., and Blakely, R. D. (2009). Enhanced
activity of human serotonin transporter variants associated with autism.
Philos. Trans. R. Soc. Lond. B Biol. Sci. 364, 163–173. doi: 10.1098/rstb.
2008.0143
Qian, Y., Melikian, H. E., Rye, D. B., Levey, A. I., and Blakely, R. D. (1995).
Identiﬁcation and characterization of antidepressant-sensitive serotonin
transporter proteins using site-speciﬁc antibodies. J. Neurosci. 15, 1261–1274.
Rioux, A., Fabre, V., Lesch, K. P., Moessner, R., Murphy, D. L., Lanfumey, L.,
et al. (1999). Adaptive changes of serotonin 5-HT2A receptors in mice lacking
the serotonin transporter. Neurosci. Lett. 262, 113–116. doi: 10.1016/S0304-
3940(99)00049-X
Sager, J. J., and Torres, G. E. (2011). Proteins interacting with monoamine
transporters: current state and future challenges. Biochemistry 50, 7295–7310.
doi: 10.1021/bi200405c
Scheiﬀele, P., Fan, J., Choih, J., Fetter, R., and Seraﬁni, T. (2000). Neuroligin
expressed in nonneuronal cells triggers presynaptic development in contacting
axons. Cell 101, 657–669. doi: 10.1016/S0092-8674(00)80877-6
Schneider, C., Newman, R. A., Sutherland, D. R., Asser, U., and Greaves, M. F.
(1982). A one-step puriﬁcation of membrane proteins using a high eﬃciency
immunomatrix. J. Biol. Chem. 257, 10766–10769.
Soiza-Reilly, M., Anderson, W. B., Vaughan, C. W., and Commons, K. G.
(2013). Presynaptic gating of excitation in the dorsal raphe nucleus by
GABA. Proc. Natl. Acad. Sci. U.S.A. 110, 15800–15805. doi: 10.1073/pnas.1304
505110
Srejic, L. R., Hamani, C., and Hutchison,W.D. (2015). High-frequency stimulation
of the medial prefrontal cortex decreases cellular ﬁring in the dorsal raphe. Eur.
J. Neurosci. 41, 1219–1226. doi: 10.1111/ejn.12856
Steiner, J. A., Carneiro, A. M., and Blakely, R. D. (2008). Going with the ﬂow:
traﬃcking-dependent and –independent regulation of serotonin transport.
Traﬃc 9, 1393–1402. doi: 10.1111/j.1600-0854.2008.00757.x
Steiner, J. A., Carneiro, A. M., Wright, J., Matthies, H. J., Prasad, H. C., Nicki,
C. K., et al. (2009). cGMP-dependent protein kinase Ialpha associates with the
antidepressant-sensitive serotonin transporter and dictates rapid modulation of
serotonin uptake.Mol. Brain 2, 26. doi: 10.1186/1756-6606-2-26
Sun, C., Cheng, M. C., Qin, R., Liao, D. L., Chen, T. T., Koong, F. J., et al.
(2011). Identiﬁcation and functional characterization of rare mutations of the
neuroligin-2 gene (NLGN2) associated with schizophrenia. Hum. Mol. Genet.
20, 3042–3051. doi: 10.1093/hmg/ddr208
Sutcliﬀe, J. S., Delahanty, R. J., Prasad, H. C., McCauley, J. L., Han, Q., Jiang, L.,
et al. (2005). Allelic heterogeneity at the serotonin transporter locus (SLC6A4)
confers susceptibility to autism and rigid-compulsive behaviors. Am. J. Hum.
Genet. 77, 265–279. doi: 10.1086/432648
Takacs, V. T., Freund, T. F., and Nyiri, G. (2013). Neuroligin 2 is expressed
in synapses established by cholinergic cells in the mouse brain. PLoS ONE
8:e72450. doi: 10.1371/journal.pone.0072450
Tao, R., and Auerbach, S. B. (2002). GABAergic and glutamatergic aﬀerents in the
dorsal raphe nucleus mediate morphine-induced increases in serotonin eﬄux
in the rat central nervous system. J. Pharmacol. Exp. Ther. 303, 704–710. doi:
10.1124/jpet.102.038133
Tao-Cheng, J. H., and Zhou, F. C. (1999). Diﬀerential polarization of
serotonin transporters in axons versus soma-dendrites: an immunogold
electron microscopy study. Neuroscience 94, 821–830. doi: 10.1016/S0306-
4522(99)00373-5
Thompson, B. J., Jessen, T., Henry, L. K., Field, J. R., Gamble, K. L., Gresch, P. J.,
et al. (2011). Transgenic elimination of high-aﬃnity antidepressant and cocaine
sensitivity in the presynaptic serotonin transporter. Proc. Natl. Acad. Sci. U.S.A.
108, 3785–3790. doi: 10.1073/pnas.1011920108
Treutlein, B., Gokce, O., Quake, S. R., and Sudhof, T. C. (2014). Cartography
of neurexin alternative splicing mapped by single-molecule long-read
mRNA sequencing. Proc. Natl. Acad. Sci. U.S.A. 111, E1291–E1299. doi:
10.1073/pnas.1403244111
Vaughan, R. A., Uhl, G., and Kuhar, M. J. (1993). Recognition of dopamine
transporters by antipeptide antibodies. Mol. Cell. Neurosci. 4, 209–215. doi:
10.1006/mcne.1993.1025
Veenstra-VanderWeele, J., Muller, C. L., Iwamoto, H., Sauer, J. E., Owens, W. A.,
Shah, C. R., et al. (2012). Autism gene variant causes hyperserotonemia,
serotonin receptor hypersensitivity, social impairment and repetitive behavior.
Proc. Natl. Acad. Sci. U.S.A. 109, 5469–5474. doi: 10.1073/pnas.1112345109
Voyiaziakis, E., Evgrafov, O., Li, D., Yoon, H. J., Tabares, P., Samuels, J., et al.
(2011). Association of SLC6A4 variants with obsessive-compulsive disorder
in a large multicenter US family study. Mol. Psychiatry 16, 108–120. doi:
10.1038/mp.2009.100
Weissbourd,B., Ren, J., DeLoach, K. E., Guenthner, C. J.,Miyamichi, K., and Luo, L.
(2014). Presynaptic partners of dorsal raphe serotonergic and GABAergic
neurons. Neuron 83, 645–662. doi: 10.1016/j.neuron.2014.06.024
Wohr, M., Silverman, J. L., Scattoni, M. L., Turner, S. M., Harris, M. J., Saxena, R.,
et al. (2013). Developmental delays and reduced pup ultrasonic vocalizations
but normal sociability in mice lacking the postsynaptic cell adhesion
protein neuroligin2. Behav. Brain Res. 251, 50–64. doi: 10.1016/j.bbr.2012.
07.024
Wolters, D. A., Washburn, M. P., and Yates, J. R. I. I. I. (2001). An automated
multidimensional protein identiﬁcation technology for shotgun proteomics.
Anal. Chem. 73, 5683–5690. doi: 10.1021/ac010617e
Ye, R., Carneiro, A. M., Airey, D., Sanders-Bush, E., Williams, R. W., Lu, L., et al.
(2014a). Evaluation of heritable determinants of blood and brain serotonin
homeostasis using recombinant inbred mice. Genes Brain Behav. 13, 247–260.
doi: 10.1111/gbb.12092
Ye, R., Carneiro, A. M., Han, Q., Airey, D., Sanders-Bush, E., Zhang, B., et al.
(2014b). Quantitative trait loci mapping and gene network analysis implicate
protocadherin-15 as a determinant of brain serotonin transporter expression.
Genes Brain Behav. 13, 261–275. doi: 10.1111/gbb.12119
Frontiers in Synaptic Neuroscience | www.frontiersin.org 16 January 2016 | Volume 7 | Article 20
Ye et al. Neuroligin 2 Interactions with the Serotonin Transporter
Zhao, S., Ting, J. T., Atallah, H. E., Qiu, L., Tan, J., Gloss, B., et al. (2011). Cell
type-speciﬁc channelrhodopsin-2 transgenic mice for optogenetic dissection of
neural circuitry function. Nat. Methods 8, 745–752. doi: 10.1038/nmeth.1668
Zhu, C. B., Lindler, K. M., Campbell, N. G., Sutcliﬀe, J. S., Hewlett, W. A.,
and Blakely, R. D. (2011). Colocalization and regulated physical association
of presynaptic serotonin transporters with A(3) adenosine receptors. Mol.
Pharmacol. 80, 458–465. doi: 10.1124/mol.111.071399
Zhu, C. B., Lindler, K. M., Owens, A. W., Daws, L. C., Blakely, R. D.,
and Hewlett, W. A. (2010). Interleukin-1 receptor activation by systemic
lipopolysaccharide induces behavioral despair linked to MAPK regulation of
CNS serotonin transporters. Neuropsychopharmacology 35, 2510–2520. doi:
10.1038/npp.2010.116
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or ﬁnancial relationships that could
be construed as a potential conﬂict of interest.
Copyright © 2016 Ye, Quinlan, Iwamoto, Wu, Green, Jetter, McMahon, Veestra-
VanderWeele, Levitt and Blakely. This is an open-access article distributed
under the terms of the Creative Commons Attribution License (CC BY). The
use, distribution or reproduction in other forums is permitted, provided the
original author(s) or licensor are credited and that the original publication in
this journal is cited, in accordance with accepted academic practice. No use,
distribution or reproduction is permitted which does not comply with these
terms.
Frontiers in Synaptic Neuroscience | www.frontiersin.org 17 January 2016 | Volume 7 | Article 20
